Patents by Inventor Larry Mimms

Larry Mimms has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11860170
    Abstract: An assay method for detecting the presence or amounts of VCAM-1 and A2M in a sample using fluorescence resonance energy transfer (FRET).
    Type: Grant
    Filed: October 22, 2021
    Date of Patent: January 2, 2024
    Assignee: ProciseDX Inc.
    Inventors: Hongyu Chen, Limin Liu, Stefan Westin, Michael Hale, Larry Mimms
  • Publication number: 20220283173
    Abstract: The present disclosure provides assay methods to detect and measure proteins in order to distinguish between a bacterial infection and a viral infection.
    Type: Application
    Filed: May 18, 2022
    Publication date: September 8, 2022
    Applicant: ProciseDx Inc.
    Inventors: Larry Mimms, Michael Hale
  • Publication number: 20220137035
    Abstract: An assay method for detecting and measuring the presence or amount of glycated hemoglobin in a sample using fluorescence resonance energy transfer (FRET).
    Type: Application
    Filed: November 8, 2021
    Publication date: May 5, 2022
    Applicant: Procisedx Inc.
    Inventors: Larry Mimms, Mark Renshaw, Kevin Chon, Michael Hale
  • Publication number: 20100151591
    Abstract: The present invention provides compositions and methods for detecting the presence of an analyte in a sample. Exemplary compositions comprise macrocyclic lanthanide complexes that are useful for transferring energy to an energy transfer acceptor to indicate the presence of the analyte. The compositions and methods are particularly suited for detecting antibodies in a sample.
    Type: Application
    Filed: November 2, 2009
    Publication date: June 17, 2010
    Inventors: Nathaniel G. Butlin, Larry Mimms